查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1446492

DNA 定序市场规模、份额、趋势分析报告：按产品/服务、按技术、按工作流程、按应用、按最终用途、按地区、细分市场预测，2024-2030 年

DNA Sequencing Market Size, Share & Trends Analysis Report By Product & Service, By Technology, By Workflow, By Application, By End-use, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 130 Pages | 商品交期: 2-10个工作天内

价格

DNA 定序市场成长与趋势：

Grand View Research, Inc.最新报告显示，预计2030年全球DNA定序市场规模将达到482.2亿美元，2024年至2030年复合年增长率为21.65%。

人工智慧（AI）的结合将增加基因组资料在临床实践中的效用，并为基因组资料分析的进步创造新的领域。 2020 年 5 月，Nvidia 公司开发了新的人工智慧工具、基因测序软体和语音辨识技术来支援 COVID-19 研究工作。因此，人工智慧将加速临床诊断中的变异註释和优先排序，并推动市场发展。

自人类基因计划完成以来，DNA序列测定的成本迅速下降。十年前，对一个人的基因组进行测序的成本约为 50,000 美元，但现在最大的基因组中心的成本接近 600 美元。最近，2020 年 2 月，华大基因声称将基因组定序的成本降低至 100 美元。预计这将扩大其在产前检测、癌症筛检和研究中的应用。

显着降低的成本和资金筹措的可用性导致多家新兴企业进入市场。例如，2020年1月，美国新兴企业Omniome筹集了6,000万美元的C轮资金筹措，以加速其基因定序平台的后期产品开拓和产品上市，从而支持扩张。

DNA 定序市场报告亮点

  • 以实惠的价格提供更多的服务，以及咨询服务、培训课程和客户支持，预计将在预测期内推动服务业以最快的速度成长。
  • 随着新系统的推出，第三代技术的持续技术进步预计将推动该领域实现良好的复合年增长率。
  • 例如，2019年7月，Oxford Nanopore推出了GridION Mk1，这是一款桌上型、灵活的NGS和资料分析仪器，可增强该公司GridION X5系统的效能。
  • 根据工作流程，资料分析步骤预计将在预测期内实现显着的复合年增长率。
  • 引入配备 HTS-flow 的工作流程管理系统，透过从实验室管理系统取得资料并使用简单的 GUI 管理资料分析工作资料。
  • 这些技术已在肿瘤学领域获得广泛接受，用于对基因突变进行测序和编目，以开发癌症诊断和治疗。
  • 全球癌症患者数量的不断增加正在推动对肿瘤学的需求。预计2020年美国将新增近180万名癌症病例。
  • 在预测期内，临床研究领域预计将呈现最快的成长速度，其次是医院和诊所。
  • 公司和政府机构为扩大医院和诊断中心对 COVID-19 诊断使用基于 NGS 的诊断测试的机会而做出的努力预计将推动医院和诊所领域以良好的速度发展。
  • 在亚太地区，由于涉及使用这些工具的众多研究项目，预计市场在预测期内将以最高的复合年增长率发展。
  • 例如，2019年10月，科学技术研究院的研究人员创建了亚洲人口最大的遗传资料，以帮助诊断罕见疾病。

目录

第一章调查方法与范围

第 2 章执行摘要

第 3 章 DNA 定序市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/补充市场展望。
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • DNA定序市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析
    • COVID-19感染疾病的影响分析

第四章 DNA 定序市场：产品与服务的估算与趋势分析

  • 2023 年和 2030 年产品和服务的市场占有率
  • 2018年至2030年市场规模、预测、趋势分析
    • 消耗品
    • 用具
    • 服务

第五章 DNA序列市场：技术预估与趋势分析

  • 2023年及2030年技术市场占有率
  • 2018年至2030年市场规模、预测、趋势分析
    • Sanger法
    • NGS
    • 第三代定序

第六章 DNA定序市场：工作流程估算与趋势分析

  • 2023 年及 2030 年工作流程市场占有率
  • 2018年至2030年市场规模、预测与趋势分析
    • 前序
    • 定序
    • 资料分析

第七章 DNA序列市场：使用量估算及趋势分析

  • 2023年及2030年应用市场占有率
  • 2018年至2030年市场规模、预测与趋势分析
    • 肿瘤学
    • 生殖健康
    • 临床试验
    • 农业基因组学/法医学
    • HLA型检测
    • 总体基因体学、流行病学和药物开发
    • 消费者基因体学
    • 其他的

第八章 DNA序列市场：最终用途估算与趋势分析

  • 2023 年及 2030 年最终用途市场占有率
  • 2018年至2030年市场规模、预测与趋势分析

第九章 DNA序列市场：区域估算及趋势分析

  • 2023 年及 2030 年区域市场占有率分析
  • 北美洲
    • 2018年至2030年北美市场预估与预测
    • 美国
    • 加拿大
  • 欧洲
    • 2018年至2030年欧洲市场估计与预测
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麦
  • 亚太地区
    • 2018年至2030年亚太市场估计与预测
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 2018年至2030年拉丁美洲市场估计与预测
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东/非洲
    • MEA 市场估计/预测
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第10章竞争形势

  • 公司/竞争对手分类
  • 策略规划
  • 2023 年企业市场分析
  • 公司简介/名单
    • Thermo Fisher Scientific, Inc
    • Agilent Technology
    • Illumina, Inc.
    • QIAGEN
    • F. Hoffmann-La Roche Ltd.
    • Oxford Nanopore Technologies plc.
    • Macrogen, Inc.
    • PerkinElmer Genomics
    • PacBio
    • BGI
    • Bio-Rad Laboratories, Inc.
    • Myriad Genetics
    • PierianDx
    • Partek Incorporated
    • Eurofins Scientific
Product Code: GVR-4-68039-070-4

DNA Sequencing Market Growth & Trends:

The global DNA sequencing market size is expected to reach USD 48.22 billion by 2030, expanding at a CAGR of 21.65% from 2024 to 2030, according to a new report by Grand View Research, Inc. The incorporation of Artificial Intelligence (AI) has increased the utility of genomic data in clinical practices and thus creates a new frontier in the advancement of genomic data analysis. In May 2020, Nvidia Corporation developed new AI tools, genomic sequencing software, and speech recognition technologies to aid the COVID-19 research efforts. Thus, AI accelerates the variant annotation and prioritization in the clinical diagnosis, which drives the market.

Since the completion of the Human Genome Project, the DNA sequencing cost has declined precipitously. The cost of decoding one person's genome was around USD 50,000 a decade ago and currently has reached nearly USD 600 in the largest genomic centers. Recently, in February 2020, BGI claimed to reduce the cost to sequence the genome to USD 100. This is expected to expand the use of this technology for prenatal tests, cancer screening, and research studies.

With a significant decrease in cost coupled with the availability of funding, several start-ups have entered the market. For instance, in January 2020, Omniome, a startup firm from the U.S., raised USD 60.0 million in Series C financing to speed up the late-stage product development and product launch of its genetic sequencing platform, which consequently fuels market progression.

DNA Sequencing Market Report Highlights:

  • Rise in the availability of services at affordable prices along with consulting services, training courses, and customer support are anticipated to drive the services segment at the fastest growth rate over the forecast period
  • Constant technological advancements in third-generation techniques with the launch of new systems are expected to drive this segment at a lucrative CAGR
  • For instance, in July 2019, Oxford Nanopore launched GridION Mk1, a benchtop, flexible NGS, data analysis device that improves the performance of the company's GridION X5 system
  • On the basis of workflow, the data analysis step is anticipated to register a considerable CAGR throughout the forecast period
  • The advent of workflow management systems with HTS-flow retrieves data from laboratory management systems and manages data analysis through a simple graphical user interface, subsequently streamlining the data analysis workflow
  • These technologies are widely accepted in the oncology field to sequence and catalog gene mutations for the development of cancer diagnostic and therapeutics
  • A rise in cancer cases globally is driving demand for oncology. It is estimated that there would be nearly 1.8 million new cancer cases in 2020 in the U.S.
  • The clinical research segment is projected to witness the fastest growth rate over the forecast period, followed by hospitals and clinics
  • Efforts undertaken by companies and government agencies to broaden the accessibility for NGS-based diagnostic tests in the hospitals and diagnostic centers for COVID-19 diagnosis is anticipated to drive the hospitals and clinics segment at a lucrative pace
  • In Asia Pacific, the market is expected to progress with the highest CAGR over the forecast period owing to numerous research programs that involve the usage of these tools
  • For instance, in October 2019, researchers from the Agency for Science, Technology and Research's Genome Institute of Singapore created the largest genetic databank of Asian populations to support the diagnosis of rare diseases

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product & Service
    • 1.2.2. Technology
    • 1.2.3. Workflow
    • 1.2.4. Application
    • 1.2.5. End-use
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. DNA Sequencing Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Technological advancements in sequencing techniques
      • 3.2.1.2. Rising interest in genomics research and personalized medicine
      • 3.2.1.3. Increasing applications of DNA sequencing in clinical diagnostics
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Data storage and management challenges
      • 3.2.2.2. Ethical and privacy concerns related to the use of sequencing technologies.
  • 3.3. DNA Sequencing Market Analysis Tools
    • 3.3.1. Industry analysis - Porter's
    • 3.3.2. PESTEL analysis
    • 3.3.3. COVID-19 impact analysis

Chapter 4. DNA Sequencing Market: Product & Service Estimates & Trend Analysis

  • 4.1. Product & Service Market Share, 2023 & 2030
  • 4.2. Market Size & Forecasts And Trend Analyses, 2018 To 2030 For The Following
    • 4.2.1. Consumables
      • 4.2.1.1. Consumables market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.2.2. Instruments
      • 4.2.2.1. Instruments market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.2.3. Services
      • 4.2.3.1. Services market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. DNA Sequencing Market: Technology Estimates & Trend Analysis

  • 5.1. Technology Market Share, 2023 & 2030
  • 5.2. Market Size & Forecasts And Trend Analyses, 2018 To 2030 For The Following
    • 5.2.1. Sanger sequencing
      • 5.2.1.1. Sanger sequencing market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.2.2. Next-generation sequencing (NGS)
      • 5.2.2.1. Next-generation sequencing (NGS) market estimates and forecasts 2018 to 2030 (USD Million)
      • 5.2.2.2. Whole genome sequencing (WGS)
      • 5.2.2.2.1. Whole genome sequencing (WGS) market estimates and forecasts 2018 to 2030 (USD Million)
      • 5.2.2.3. Whole exome sequencing (WES)
      • 5.2.2.3.1. Whole exome sequencing (WES) market estimates and forecasts 2018 to 2030 (USD Million)
      • 5.2.2.4. Targeted sequencing & resequencing
      • 5.2.2.4.1. Targeted sequencing & resequencing market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.2.3. Third generation dna sequencing
      • 5.2.3.1. Third generation dna sequencing market estimates and forecasts 2018 to 2030 (USD Million)
      • 5.2.3.2. Single-molecule real-time sequencing (SMRT)
      • 5.2.3.2.1. Single-molecule real-time sequencing (SMRT) market estimates and forecasts 2018 to 2030 (USD Million)
      • 5.2.3.3. Nanopore sequencing
      • 5.2.3.3.1. Nanopore sequencing market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. DNA Sequencing Market: Workflow Estimates & Trend Analysis

  • 6.1. Workflow Market Share, 2023 & 2030
  • 6.2. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 6.2.1. Pre-sequencing
      • 6.2.1.1. Pre-sequencing market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.2.2. Sequencing
      • 6.2.2.1. Sequencing Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.2.3. Data Analysis
      • 6.2.3.1. Data analysis Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. DNA Sequencing Market: Application Estimates & Trend Analysis

  • 7.1. Application Market Share, 2023 & 2030
  • 7.2. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 7.2.1. Oncology
      • 7.2.1.1. Oncology Market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.2.2. Reproductive Health
      • 7.2.2.1. Reproductive health market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.2.3. Clinical Investigation
      • 7.2.3.1. Clinical investigation Market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.2.4. Agrigenomics & Forensics
      • 7.2.4.1. Agrigenomics & forensics market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.2.5. HLA Typing/Immune System Monitoring
      • 7.2.5.1. HLA Typing/Immune System Monitoring market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.2.6. Metagenomics, Epidemiology, & Drug Development
      • 7.2.6.1. Metagenomics, epidemiology, & drug development market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.2.7. Consumer Genomics
      • 7.2.7.1. Consumer genomics market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.2.8. Others
      • 7.2.8.1. Others Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. DNA Sequencing Market: End-use Estimates & Trend Analysis

  • 8.1. End-use Market Share, 2023 & 2030
  • 8.2. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 8.2.1. Academic Research
      • 8.2.1.1. Academic research market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.2.2. Clinical Research
      • 8.2.2.1. Clinical research market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.2.3. Hospitals & Clinics
      • 8.2.3.1. Hospitals & clinics market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.2.4. Pharmaceutical & Biotechnology Companies
      • 8.2.4.1. Pharmaceutical & biotechnology companies market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.2.5. Others
      • 8.2.5.1. Others Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 9. DNA Sequencing Market: Regional Estimates & Trend Analysis

  • 9.1. Regional Market Share Analysis, 2023 & 2030
  • 9.2. North America
    • 9.2.1. North America market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.2.2. U.S.
      • 9.2.2.1. Key country dynamics
      • 9.2.2.2. Regulatory framework
      • 9.2.2.3. Target disease prevalence
      • 9.2.2.4. Competitive scenario
      • 9.2.2.5. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.2.3. Canada
      • 9.2.3.1. Key country dynamics
      • 9.2.3.2. Regulatory framework
      • 9.2.3.3. Target disease prevalence
      • 9.2.3.4. Competitive scenario
      • 9.2.3.5. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.3. Europe
    • 9.3.1. Europe market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.3.2. UK
      • 9.3.2.1. Key country dynamics
      • 9.3.2.2. Regulatory framework
      • 9.3.2.3. Target disease prevalence
      • 9.3.2.4. Competitive scenario
      • 9.3.2.5. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.3.3. Germany
      • 9.3.3.1. Key country dynamics
      • 9.3.3.2. Regulatory framework
      • 9.3.3.3. Target disease prevalence
      • 9.3.3.4. Competitive scenario
      • 9.3.3.5. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.3.4. France
      • 9.3.4.1. Key country dynamics
      • 9.3.4.2. Regulatory framework
      • 9.3.4.3. Target disease prevalence
      • 9.3.4.4. Competitive scenario
      • 9.3.4.5. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.3.5. Italy
      • 9.3.5.1. Key country dynamics
      • 9.3.5.2. Regulatory framework
      • 9.3.5.3. Target disease prevalence
      • 9.3.5.4. Competitive scenario
      • 9.3.5.5. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.3.6. Spain
      • 9.3.6.1. Key country dynamics
      • 9.3.6.2. Regulatory framework
      • 9.3.6.3. Target disease prevalence k
      • 9.3.6.4. Competitive scenario
      • 9.3.6.5. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.3.7. Norway
      • 9.3.7.1. Key country dynamics
      • 9.3.7.2. Regulatory framework
      • 9.3.7.3. Target disease prevalence
      • 9.3.7.4. Competitive scenario
      • 9.3.7.5. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.3.8. Sweden
      • 9.3.8.1. Key country dynamics
      • 9.3.8.2. Regulatory framework
      • 9.3.8.3. Target disease prevalence
      • 9.3.8.4. Competitive scenario
      • 9.3.8.5. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.3.9. Denmark
      • 9.3.9.1. Key country dynamics
      • 9.3.9.2. Regulatory framework
      • 9.3.9.3. Target disease prevalence
      • 9.3.9.4. Competitive scenario
      • 9.3.9.5. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.4. Asia Pacific
    • 9.4.1. Asia Pacific market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.4.2. Japan
      • 9.4.2.1. Key country dynamics
      • 9.4.2.2. Regulatory framework
      • 9.4.2.3. Target disease prevalence
      • 9.4.2.4. Competitive scenario
      • 9.4.2.5. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.4.3. China
      • 9.4.3.1. Key country dynamics
      • 9.4.3.2. Regulatory framework
      • 9.4.3.3. Target disease prevalence
      • 9.4.3.4. Competitive scenario
      • 9.4.3.5. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.4.4. India
      • 9.4.4.1. Key country dynamics
      • 9.4.4.2. Regulatory framework
      • 9.4.4.3. Target disease prevalence
      • 9.4.4.4. Competitive scenario
      • 9.4.4.5. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.4.5. Australia
      • 9.4.5.1. Key country dynamics
      • 9.4.5.2. Regulatory framework
      • 9.4.5.3. Target disease prevalence
      • 9.4.5.4. Competitive scenario
      • 9.4.5.5. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.4.6. South Korea
      • 9.4.6.1. Key country dynamics
      • 9.4.6.2. Regulatory framework
      • 9.4.6.3. Target disease prevalence
      • 9.4.6.4. Competitive scenario
      • 9.4.6.5. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.4.7. Thailand
      • 9.4.7.1. Key country dynamics
      • 9.4.7.2. Regulatory framework
      • 9.4.7.3. Target disease prevalence
      • 9.4.7.4. Competitive scenario
      • 9.4.7.5. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.5. Latin America
    • 9.5.1. Latin America market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.5.2. Brazil
      • 9.5.2.1. Key country dynamics
      • 9.5.2.2. Regulatory framework
      • 9.5.2.3. Target disease prevalence
      • 9.5.2.4. Competitive scenario
      • 9.5.2.5. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.5.3. Mexico
      • 9.5.3.1. Key country dynamics
      • 9.5.3.2. Regulatory framework
      • 9.5.3.3. Target disease prevalence
      • 9.5.3.4. Competitive scenario
      • 9.5.3.5. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.5.4. Argentina
      • 9.5.4.1. Key country dynamics
      • 9.5.4.2. Regulatory framework
      • 9.5.4.3. Target disease prevalence
      • 9.5.4.4. Competitive scenario
      • 9.5.4.5. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.6. MEA
    • 9.6.1. MEA market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.6.2. South Africa
      • 9.6.2.1. Key country dynamics
      • 9.6.2.2. Regulatory framework
      • 9.6.2.3. Competitive scenario
      • 9.6.2.4. Target disease prevalence
      • 9.6.2.5. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.6.3. Saudi Arabia
      • 9.6.3.1. Key country dynamics
      • 9.6.3.2. Regulatory framework
      • 9.6.3.3. Competitive scenario
      • 9.6.3.4. Target disease prevalence
      • 9.6.3.5. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.6.4. UAE
      • 9.6.4.1. Key country dynamics
      • 9.6.4.2. Regulatory framework
      • 9.6.4.3. Target disease prevalence
      • 9.6.4.4. Competitive scenario
      • 9.6.4.5. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.6.5. Kuwait
      • 9.6.5.1. Key country dynamics
      • 9.6.5.2. Regulatory framework
      • 9.6.5.3. Competitive scenario
      • 9.6.5.4. Target disease prevalence
      • 9.6.5.5. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 10. Competitive Landscape

  • 10.1. Company/Competition Categorization
  • 10.2. Strategy Mapping
  • 10.3. Company Market Position Analysis, 2023
  • 10.4. Company Profiles/Listing
    • 10.4.1. Thermo Fisher Scientific, Inc
      • 10.4.1.1. Company overview
      • 10.4.1.2. Financial performance
      • 10.4.1.3. Product & service benchmarking
      • 10.4.1.4. Strategic initiatives
    • 10.4.2. Agilent Technology
      • 10.4.2.1. Company overview
      • 10.4.2.2. Financial performance
      • 10.4.2.3. Product & service benchmarking
      • 10.4.2.4. Strategic initiatives
    • 10.4.3. Illumina, Inc.
      • 10.4.3.1. Company overview
      • 10.4.3.2. Financial performance
      • 10.4.3.3. Product & service benchmarking
      • 10.4.3.4. Strategic initiatives
    • 10.4.4. QIAGEN
      • 10.4.4.1. Company overview
      • 10.4.4.2. Financial performance
      • 10.4.4.3. Product & service benchmarking
      • 10.4.4.4. Strategic initiatives
    • 10.4.5. F. Hoffmann-La Roche Ltd.
      • 10.4.5.1. Company overview
      • 10.4.5.2. Financial performance
      • 10.4.5.3. Product & service benchmarking
      • 10.4.5.4. Strategic initiatives
    • 10.4.6. Oxford Nanopore Technologies plc.
      • 10.4.6.1. Company overview
      • 10.4.6.2. Financial performance
      • 10.4.6.3. Product & service benchmarking
      • 10.4.6.4. Strategic initiatives
    • 10.4.7. Macrogen, Inc.
      • 10.4.7.1. Company overview
      • 10.4.7.2. Financial performance
      • 10.4.7.3. Product & service benchmarking
      • 10.4.7.4. Strategic initiatives
    • 10.4.8. PerkinElmer Genomics
      • 10.4.8.1. Company overview
      • 10.4.8.2. Financial performance
      • 10.4.8.3. Product & service benchmarking
      • 10.4.8.4. Strategic initiatives
    • 10.4.9. PacBio
      • 10.4.9.1. Company overview
      • 10.4.9.2. Financial performance
      • 10.4.9.3. Product & service benchmarking
      • 10.4.9.4. Strategic initiatives
    • 10.4.10. BGI
      • 10.4.10.1. Company overview
      • 10.4.10.2. Financial performance
      • 10.4.10.3. Product & service benchmarking
      • 10.4.10.4. Strategic initiatives
    • 10.4.11. Bio-Rad Laboratories, Inc.
      • 10.4.11.1. Company overview
      • 10.4.11.2. Financial performance
      • 10.4.11.3. Product & service benchmarking
      • 10.4.11.4. Strategic initiatives
    • 10.4.12. Myriad Genetics
      • 10.4.12.1. Company overview
      • 10.4.12.2. Financial performance
      • 10.4.12.3. Product & service benchmarking
      • 10.4.12.4. Strategic initiatives
    • 10.4.13. PierianDx
      • 10.4.13.1. Company overview
      • 10.4.13.2. Financial performance
      • 10.4.13.3. Product & service benchmarking
      • 10.4.13.4. Strategic initiatives
    • 10.4.14. Partek Incorporated
      • 10.4.14.1. Company overview
      • 10.4.14.2. Financial performance
      • 10.4.14.3. Product & service benchmarking
      • 10.4.14.4. Strategic initiatives
    • 10.4.15. Eurofins Scientific
      • 10.4.15.1. Company overview
      • 10.4.15.2. Financial performance
      • 10.4.15.3. Product & service benchmarking
      • 10.4.15.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 Global DNA sequencing market, by region, 2018 - 2030 (USD Million)
  • Table 3 Global DNA sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 4 Global DNA sequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 5 Global DNA sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 6 Global DNA sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 7 Global DNA sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 8 North America DNA sequencing market, by country, 2018 - 2030 (USD Million)
  • Table 9 North America DNA sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 10 North America DNA sequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 11 North America DNA sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 12 North America DNA sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 13 North America DNA sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 14 U.S. DNA sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 15 U.S. DNA sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 16 U.S. DNA sequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 17 U.S. DNA sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 18 U.S. DNA sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 19 Canada DNA sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 20 Canada DNA sequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 21 Canada DNA sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 22 Canada DNA sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 23 Canada DNA sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 24 Europe DNA sequencing market, by country, 2018 - 2030 (USD Million)
  • Table 25 Europe DNA sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 26 Europe DNA sequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 27 Europe DNA sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 28 Europe DNA sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 29 U.S. DNA sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 30 Germany DNA sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 31 Germany DNA sequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 32 Germany DNA sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 33 Germany DNA sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 34 Germany DNA sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 35 UK DNA sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 36 UK DNA sequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 37 UK DNA sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 38 UK DNA sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 39 UK DNA sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 40 France DNA sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 41 France DNA sequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 42 France DNA sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 43 France DNA sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 44 France DNA sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 45 Italy DNA sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 46 Italy DNA sequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 47 Italy DNA sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 48 Italy DNA sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 49 Italy DNA sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 50 Spain DNA sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 51 Spain DNA sequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 52 Spain DNA sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 53 Spain DNA sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 54 Spain DNA sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 55 Denmark DNA sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 56 Denmark DNA sequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 57 Denmark DNA sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 58 Denmark DNA sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 59 Denmark DNA sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 60 Sweden DNA sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 61 Sweden DNA sequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 62 Sweden DNA sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 63 Sweden DNA sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 64 Sweden DNA sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 65 Norway DNA sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 66 Norway DNA sequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 67 Norway DNA sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 68 Norway DNA sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 69 Norway DNA sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 70 Asia Pacific DNA sequencing market, by country, 2018 - 2030 (USD Million)
  • Table 71 Asia Pacific DNA sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 72 Asia Pacific DNA sequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 73 Asia Pacific DNA sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 74 Asia Pacific DNA sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 75 Asia Pacific DNA sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 76 China DNA sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 77 China DNA sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 78 China DNA sequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 79 China DNA sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 80 China DNA sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 81 Japan DNA sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 82 Japan DNA sequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 83 Japan DNA sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 84 Japan DNA sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 85 Japan DNA sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 86 India DNA sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 87 India DNA sequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 88 India DNA sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 89 India DNA sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 90 India DNA sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 91 South Korea DNA sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 92 South Korea DNA sequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 93 South Korea DNA sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 94 South Korea DNA sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 95 South Korea DNA sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 96 Australia DNA sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 97 Australia DNA sequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 98 Australia DNA sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 99 Australia DNA sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 100 Australia DNA sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 101 Thailand DNA sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 102 Thailand DNA sequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 103 Thailand DNA sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 104 Thailand DNA sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 105 Thailand DNA sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 106 Latin America DNA sequencing market, by country, 2018 - 2030 (USD Million)
  • Table 107 Latin America DNA sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 108 Latin America DNA sequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 109 Latin America DNA sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 110 Latin America DNA sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 111 Latin America DNA sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 112 Brazil DNA sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 113 Brazil DNA sequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 114 Brazil DNA sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 115 Brazil DNA sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 116 Brazil DNA sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 117 Mexico DNA sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 118 Mexico DNA sequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 119 Mexico DNA sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 120 Mexico DNA sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 121 Mexico DNA sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 122 Argentina DNA sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 123 Argentina DNA sequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 124 Argentina DNA sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 125 Argentina DNA sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 126 Argentina DNA sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 127 MEA DNA sequencing market, by country, 2018 - 2030 (USD Million)
  • Table 128 MEA DNA sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 129 MEA DNA sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 130 MEA DNA sequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 131 MEA DNA sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 132 MEA DNA sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 133 South Africa DNA sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 134 South Africa DNA sequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 135 South Africa DNA sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 136 South Africa DNA sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 137 South Africa DNA sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 138 Saudi Arabia DNA sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 139 Saudi Arabia DNA sequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 140 Saudi Arabia DNA sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 141 Saudi Arabia DNA sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 142 Saudi Arabia DNA sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 143 UAE DNA sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 144 UAE DNA sequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 145 UAE DNA sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 146 UAE DNA sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 147 UAE DNA sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 148 Kuwait DNA sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 149 Kuwait DNA sequencing market, by technology, 2018 - 2030 (USD Million)
  • Table 150 Kuwait DNA sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 151 Kuwait DNA sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 152 Kuwait DNA sequencing market, by workflow, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 DNA sequencing market: market outlook
  • Fig. 9 DNA sequencing segment snapshot
  • Fig. 10 DNA sequencing competitive insights
  • Fig. 11 Parent market outlook
  • Fig. 12 DNA sequencing market driver impact
  • Fig. 13 DNA sequencing market restraint impact
  • Fig. 14 DNA sequencing market: Product & service outlook and key takeaways
  • Fig. 15 DNA sequencing market: Product & service movement analysis
  • Fig. 16 Instruments market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 17 Consumables market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 18 Services market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 19 DNA sequencing market: technology outlook and key takeaways
  • Fig. 20 DNA sequencing market: technology movement analysis
  • Fig. 21 Sanger sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 22 Next-Generation sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 Whole Genome Sequencing (WGS) market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 24 Whole Exome Sequencing (WES) market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 25 Targeted sequencing & resequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 26 Third generation sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 27 Single-Molecule Real-Time Sequencing (SMRT) market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 28 Nanopore sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 29 DNA sequencing market: workflow outlook and key takeaways
  • Fig. 30 DNA sequencing market: workflow movement analysis
  • Fig. 31 Pre-sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 32 Sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 33 Data analysis market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 34 DNA sequencing market: application outlook and key takeaways
  • Fig. 35 DNA sequencing market: application movement analysis
  • Fig. 36 Oncology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 37 Reproductive health market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 38 Clinical investigation market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 39 Agrigenomics & forensics market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 40 HLA typing/immune system monitoring market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Metagenomics, epidemiology & drug development market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Consumer genomics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 44 DNA sequencing market: end-use outlook and key takeaways
  • Fig. 45 DNA sequencing market: end-use movement analysis
  • Fig. 46 Academic research market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 47 Clinical research market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 48 Hospitals & Clinics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 49 Pharmaceutical & biotechnology companies market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 50 Other users market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 51 Global DNA sequencing market: Regional movement analysis
  • Fig. 52 Global DNA sequencing market: Regional outlook and key takeaways
  • Fig. 53 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 U.S. market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 55 Canada market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 56 Europe market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 57 UK market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 58 Germany market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 59 France market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 60 Italy market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 61 Spain market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 62 Denmark market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 63 Sweden market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 64 Norway market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 65 Asia Pacific market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 66 China market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 67 Japan market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 68 India market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 69 Thailand market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 70 South Korea market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 71 Australia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 72 Latin America market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 73 Brazil market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 74 Mexico market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 75 Argentina market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 76 Middle East and Africa market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 77 South Africa market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 78 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 79 UAE market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 80 Kuwait market estimates and forecast, 2018 - 2030 (USD Million)